Drop Test Failure during EU/UK distribution qualification: device qualification and crimp validation controls


Published on 30/12/2025

Addressing Drop Test Failures During EU/UK Distribution Qualifications

In the high-stakes world of pharmaceutical manufacturing, ensuring the integrity of aerosol devices during distribution is pivotal. An alarming trend noted is the increase in drop test failures reported during EU/UK distribution qualifications, which can jeopardize product compliance and patient safety. This article will guide professionals through a structured investigation framework to identify and rectify the root causes of such failures.

By implementing a robust investigation strategy, incorporating effective troubleshooting methodologies, and adhering to regulatory standards, pharmaceutical professionals will gain insights into controlling drop test failures. The goal is to maintain compliance with GMP and prepare for anticipated regulatory inspections.

Symptoms/Signals on the Floor or in the Lab

Drop test failures manifest primarily through inadequate performance metrics during distribution qualification phases. Common signals include:

  • Visible damage on devices post-drop tests, such as valve leakage or crimp failure.
  • Deviation reports citing inconsistent spray patterns or burst pressures.
  • Customer complaints related to product
efficacy due to defective devices.
  • Increased frequency of Out of Specification (OOS) results during stability testing.
  • Recognizing these symptoms promptly is essential for formulating an appropriate response and minimizing the impact on production schedules and market supply. Establishing a signal detection mechanism is vital for timely identification of recurring defects.

    Explore the full topic: Aerosol Formulations

    Likely Causes (by Category: Materials, Method, Machine, Man, Measurement, Environment)

    When investigating drop test failures, it is prudent to consider potential causes categorized as follows:

    Category Potential Causes
    Materials Inadequate raw material quality, defects in elastomers, or substandard crimping materials.
    Method Incorrect testing protocols, improper alignment during the drop test, or inadequate training of personnel.
    Machine Equipment malfunction, inaccurate calibration of testing machines, or wear and tear of machines.
    Man Lack of training, human error in set-up, or mishandling of products.
    Measurement Use of improper gauges or calibration errors affecting test results.
    Environment Inadequate ambient conditions, such as temperature fluctuations or humidity levels straying outside acceptable limits.

    Performing a careful assessment of these categories helps target specific areas for investigation and intervention.

    Immediate Containment Actions (First 60 Minutes)

    Upon detecting a drop test failure, immediate containment actions must be taken to prevent further discrepancies from affecting ongoing operations. Recommended steps include:

    1. Isolate Affected Lots: Segregate all products from batches under question to prevent distribution and mitigate exposure.
    2. Initiate Deviation Reports: Document the failure and involve QA to begin a formal investigation.
    3. Alert Stakeholders: Notify production, QA, engineering, and upper management for coordinated action and transparency.
    4. Review Test Protocols: Check testing records to evaluate adherence to established procedures, and ensure trained personnel executed testing correctly.
    5. Collection of Samples: Retrieve samples of damaged and non-damaged products for further analysis, ensuring you capture variance across batches.

    These actions, executed diligently within the first hour of identifying the fault, help minimize production disruptions and safeguard against potential market recalls.

    Investigation Workflow (Data to Collect + How to Interpret)

    A structured investigation workflow should begin immediately following the initial containment actions. It must involve the following steps:

    1. Collect Data: Assemble and preserve relevant records, such as batch records, testing logs, and environmental monitoring data. Use sampling strategies to build statistical reliability.
    2. Analyze Test Data: Review drop test results for commonalities among failures. Compare passed and failed batch characteristics to identify trends.
    3. Conduct Interviews: Engage personnel involved in production and testing. Insights from firsthand experience can unveil procedural deviations and equipment issues.
    4. Environmental Analysis: Check the condition of the testing environment during the drop test. Look for temperature and humidity records that may correlate with failures.

    Interpretation of collected data should follow a holistic approach, integrating findings across categories to develop a comprehensive understanding of the failure mechanism.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

    Several root cause analysis tools can streamline the investigation process. The selection of the most appropriate tool often depends on the complexity of the investigation.

    • 5-Why Analysis: Best used for straightforward issues where the root cause is directly apparent. It involves asking “why” five times to drill down to the fundamental issue. Use this method for immediate, clear-cut failures that require quick resolution.
    • Fishbone Diagram: Ideal for identifying multiple potential causes in complex scenarios (i.e., the “Ishikawa” approach). This tool can help visualize potential contributing factors across categories.
    • Fault Tree Analysis: Best suited for intricate systems where interactions among multiple components lead to a failure. This method diagrams failures in a structured format to help troubleshoot interrelated problems.

    Selecting the right tool is critical for addressing the failure effectively and preventing recurrence while ensuring compliance with GMP expectations.

    CAPA Strategy (Correction, Corrective Action, Preventive Action)

    Establishing a Corrective and Preventive Action (CAPA) strategy is essential once root causes have been identified. The CAPA plan should consist of the following components:

    1. Correction: Address the immediate issues by confirming that failed batches are quarantined and withdrawn from distribution. Ensure stability testing is conducted for all related products.
    2. Corrective Action: Implement changes based on identified root causes. This could involve enhancing material quality checks, revising testing procedures, or retraining personnel on proper techniques.
    3. Preventive Action: Set up long-term strategies to prevent similar occurrences in the future. This might include regular equipment maintenance schedules, ongoing training for employees, and more rigid supplier qualification criteria.

    Documentation of the CAPA process is necessary not only for internal records but also to demonstrate compliance with regulatory requirements during inspections.

    Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

    A robust control strategy is vital for ongoing quality management. Monitoring procedures should include:

    • Statistical Process Control (SPC): Implement SPC to track variations over time using control charts, enabling proactive identification of trends towards failure.
    • Sampling Plans: Develop appropriate sampling plans that ensure sufficient coverage of batches for quality assurance checks, specifically post-modification interventions.
    • Alarms and Alerts: Set limits and establish alarm systems within automated testing equipment to notify personnel during abnormal conditions.
    • Verification Protocols: Regularly validate the effectiveness of corrective actions taken to ensure that implemented changes lead to sustained improvements.

    These monitoring measures ensure not just immediate rectification of issues but also the preservation of quality and compliance in pharmaceutical manufacturing processes.

    Related Reads

    Validation / Re-qualification / Change Control Impact (When Needed)

    Investigators must also consider impacts on validation, re-qualification, and change control as a result of drop test failures:

    • If changes to materials or methods are necessary, formal change control processes must be followed to assess impact across all related processes and protocols.
    • Re-validation may be required for equipment or processes that were determined to have contributed to failures. This ensures continued compliance and function.
    • A thorough reevaluation of the risk management files may be warranted to incorporate lessons learned and adjustments arising from the investigation.

    Ensuring rigorous adherence to these validation processes reinforces commitment to quality principles and assures compliance with FDA, EMA, and MHRA standards.

    Inspection Readiness: What Evidence to Show (Records, Logs, Batch Docs, Deviations)

    An investigation into drop test failures should also align with inspection readiness criteria. Key documents and evidence should include:

    1. Records of all Deviations: Maintain detailed records of the drop test failures, including immediate containment actions and investigation results.
    2. Batch Manufacturing Records: Ensure that all batch-related documentation is intact, readily accessible, and accurately reflects the production history of impacted products.
    3. Testing Logs: Compile logs from all testing conducted, including any testing protocols and personnel actions.
    4. CAPA Documentation: Clearly document all steps taken during the CAPA process to establish accountability and compliance.

    Providing this information establishes organizational integrity and can significantly enhance readiness for inspections by demonstrating thorough processes and adherence to GMP regulations.

    FAQs

    What is a drop test failure?

    A drop test failure occurs when an aerosol device does not meet its defined performance criteria after being subjected to a prescribed drop test, indicating potential issues with the device’s integrity.

    How can we reduce the risk of drop test failures?

    Implementing thorough training for personnel, enhancing quality control of materials, and conducting regular machine calibrations are practical measures to minimize the risk.

    What regulatory bodies govern drop testing for pharmaceutical products?

    The FDA, EMA, and MHRA set guidelines and requirements for drop testing as part of broader quality and safety standards within pharmaceutical manufacturing.

    How often should equipment be calibrated before drop tests?

    Equipment used for drop testing should be calibrated at regular intervals as defined in the standard operating procedures (SOPs), typically at least annually.

    What should be included in a CAPA plan for drop test failures?

    A CAPA plan should include the nature of the correction, identified root causes, corrective actions taken, preventative strategies implemented, and evidence of continual monitoring.

    What role does training play in preventing drop test failures?

    Proper training ensures that personnel are equipped with the necessary skills and understanding of testing protocols, significantly reducing operator error and associated failures.

    How can we ensure compliance during inspections related to drop test processes?

    Maintain thorough and organized documentation, regularly review and update SOPs, and conduct mock inspections to ensure readiness and compliance with regulatory expectations.

    What actions should be taken immediately after a drop test failure is reported?

    Immediate actions include isolating affected lots, initiating deviation reports, alerting stakeholders, and reviewing relevant testing protocols.

    Can environmental conditions impact drop test results?

    Yes, variations in ambient temperature and humidity can significantly affect the integrity and performance of aerosol devices and should be controlled during testing.

    When is it necessary to conduct re-validation after a drop test failure?

    Re-validation is necessary when changes are made to materials, methods, or processes that could impact the device’s performance or quality assurance protocols.

    What documentation should be kept during a deviation investigation?

    Maintain documents such as deviation reports, testing logs, CAPA documentation, batch records, and any communications related to the investigation for regulatory compliance.

    Is it beneficial to involve third-party experts in investigations?

    Yes, utilizing third-party experts can provide an objective analysis and additional expertise, leading to a more comprehensive understanding of the drop test failures.

    Pharma Tip:  Leakage Failure during EU/UK distribution qualification: device qualification and crimp validation controls